NEW VISCOSUPPLEMENTS
Response to viscosupplementation with HAppyCross in hip OA: Discover the results in our published article

Response to viscosupplementation with HAppyCross in hip OA: Discover the results in our published article

Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study. Eymard et al. BMC Musculoskeletal Disorders (2017) 18:3. DOI 10.1186/s12891-016-1359-2. STUDY DESIGN Prospective, observational, multicentre, open-label study: 100 hip OA 59 men /41 women; mean age 62  (36-87) BMI 25,4 (17,9-41,8) 1 injection of HANOX-M-XL(HAppyCross®) under...
Discover our poster displayed at the ACR Congress in Washington DC in November 2016

Discover our poster displayed at the ACR Congress in Washington DC in November 2016

LABRHA participated at the ACR Congress in Washington DC, which took place from the 11th to the 16th of November 2016, and displayed a poster presenting the results of a study conducted to identify the clinical and radiological factors associated with a lack of a relevant response to viscosupplementation (VS) according to OMERACT-OARSI criteria after...
HAppyCross in ankle OA: read our new publication

HAppyCross in ankle OA: read our new publication

Imaging guidance improves the results of viscosupplementation with HANOX-M-XL in patients with ankle osteoarthritis. Results of a clinical survey in 50 patients treated in daily practice. M. Bossert; D. Boulbil; JM Parisaux; AM Bozgan; E. Richelme; T. Conrozier. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2016:9 195–199 doi: 10.4137/CMaMd.s40401. .   OBJECTIVE: The objective of this...
3rd Edition of the LABRHA European Board on Viscosupplementation / 15-16 September 2016

3rd Edition of the LABRHA European Board on Viscosupplementation / 15-16 September 2016

For the third consecutive year, LABRHA organised last 15th and 16th of September in Lyon, a new edition of the LABRHA European Board on Viscosupplementation. For this 3rd edition, the task group counted 10 experts from different European countries (EUROVISCO Group). 2 new members joined the team: Dr. Jordi Monfort, a Spanish rheumatologist and Dr....
Mannitol may shorten viscosupplementation onset of action in patients with knee OA: Read our paper

Mannitol may shorten viscosupplementation onset of action in patients with knee OA: Read our paper

Addition of Mannitol to Hyaluronic Acid may Shorten Viscosupplementation Onset of Action in Patients with Knee Osteoarthritis: Post-Hoc Analysis of A Double-blind, Controlled Trial. Eymard F, Bossert M, Lecurieux R, Maillet B, Chevalier X, et al. (2016) J Clin Exp Orthop 2: 21. doi: 10.4172/2471-8416.100021 OBJECTIVE: To compare the speed of action of three weekly...